Pilocytic Astrocytoma: Clinical Trials

3 trials for Pilocytic Astrocytoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 terminated. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 2, Terminated 1
Phase 21Active not recruiting 1

Follow Pilocytic Astrocytoma: new trials by email Literature Review of Pilocytic Astrocytoma trials Research Report on Pilocytic Astrocytoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors
Tovorafenib, Tovorafenib Drug: Pimasertib - Melanoma, Solid Tumor
Phase 1TerminatedDay One Biopharmaceuticals, Inc.442022-05-022025-08-14
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
ONC206 - Central Nervous System Neoplasms, Glioblastoma
Phase 1Active not recruitingJazz Pharmaceuticals352020-10-262026-11-09
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Mebendazole, Vincristine, Carboplatin - Pilomyxoid Astrocytoma, Pilocytic Astrocytoma
Phase 1 / Phase 2Active not recruitingJulie Krystal102013-10-222026-08-06

Narrower conditions

Astrocytoma (3)  ·  Glioblastoma (2)  ·  Glioma (2)  ·  Gliosarcoma (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Central Nervous System Neoplasms (1)  ·  Choroid Plexus Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Diffuse Intrinsic Pontine Glioma (1)  ·  Ependymoma (1)  ·  Medulloblastoma (1)  ·  Melanoma (1)  ·  Meningioma (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neuroectodermal Tumors (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Brain Diseases (2)  ·  Brain Neoplasms (2)  ·  Central Nervous System Diseases (2)  ·  Neoplasms, Neuroepithelial (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Neuroectodermal Tumors (2)  ·  Brain Stem Neoplasms (1)  ·  Bronchial Neoplasms (1)

Interventions

Bevacizumab (1)  ·  Carboplatin (1)  ·  Irinotecan (1)  ·  Mebendazole (1)  ·  ONC206 (1)  ·  Temozolomide (1)  ·  Vincristine (1)  ·  tovorafenib (1)

Sponsors

Day One Biopharmaceuticals, Inc. (1)  ·  Jazz Pharmaceuticals (1)  ·  Julie Krystal (1)

Countries

United States (3)  ·  Canada (1)

Top investigators

Julie Krystal, MD (1)

Results publications

PMID 35417530